22.93 USD
-0.32 (-1.38%)
At close: Feb 3, 2026
22.93 USD
0 (0%)
After Hours: 2/3/2026, 8:02:58 PM
BWAY gets a fundamental rating of 6 out of 10. The analysis compared the fundamentals against 186 industry peers in the Health Care Equipment & Supplies industry. BWAY has an excellent financial health rating, but there are some minor concerns on its profitability. BWAY has both an excellent growth and valuation score. This means it is growing and it is still cheap. This is a rare combination! This makes BWAY very considerable for value and growth investing!
1. Profitability
1.1 Basic Checks
- In the past year BWAY was profitable.
- In the past year BWAY had a positive cash flow from operations.
- In the past 5 years BWAY reported 4 times negative net income.
- In multiple years BWAY reported negative operating cash flow during the last 5 years.
1.2 Ratios
- BWAY's Return On Assets of 5.53% is amongst the best of the industry. BWAY outperforms 83.33% of its industry peers.
- Looking at the Return On Equity, with a value of 8.92%, BWAY belongs to the top of the industry, outperforming 83.87% of the companies in the same industry.
- BWAY has a Return On Invested Capital of 2.75%. This is in the better half of the industry: BWAY outperforms 69.89% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROIC | 2.75% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of BWAY (12.73%) is better than 89.25% of its industry peers.
- The Operating Margin of BWAY (5.78%) is better than 70.97% of its industry peers.
- BWAY has a Gross Margin of 74.92%. This is amongst the best in the industry. BWAY outperforms 86.02% of its industry peers.
- In the last couple of years the Gross Margin of BWAY has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
2. Health
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BWAY is destroying value.
- BWAY has more shares outstanding than it did 1 year ago.
- Compared to 5 years ago, BWAY has more shares outstanding
- Compared to 1 year ago, BWAY has a worse debt to assets ratio.
2.2 Solvency
- BWAY has an Altman-Z score of 6.39. This indicates that BWAY is financially healthy and has little risk of bankruptcy at the moment.
- BWAY has a better Altman-Z score (6.39) than 81.72% of its industry peers.
- BWAY has a debt to FCF ratio of 0.37. This is a very positive value and a sign of high solvency as it would only need 0.37 years to pay back of all of its debts.
- With an excellent Debt to FCF ratio value of 0.37, BWAY belongs to the best of the industry, outperforming 91.94% of the companies in the same industry.
- BWAY has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
- BWAY's Debt to Equity ratio of 0.08 is fine compared to the rest of the industry. BWAY outperforms 66.13% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Altman-Z | 6.39 |
ROIC/WACC0.32
WACC8.69%
2.3 Liquidity
- BWAY has a Current Ratio of 3.19. This indicates that BWAY is financially healthy and has no problem in meeting its short term obligations.
- Looking at the Current ratio, with a value of 3.19, BWAY is in line with its industry, outperforming 59.14% of the companies in the same industry.
- A Quick Ratio of 3.02 indicates that BWAY has no problem at all paying its short term obligations.
- Looking at the Quick ratio, with a value of 3.02, BWAY is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 |
3. Growth
3.1 Past
- BWAY shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 260.14%, which is quite impressive.
- Looking at the last year, BWAY shows a very strong growth in Revenue. The Revenue has grown by 27.08%.
- Measured over the past years, BWAY shows a quite strong growth in Revenue. The Revenue has been growing by 12.17% on average per year.
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
3.2 Future
- Based on estimates for the next years, BWAY will show a very strong growth in Earnings Per Share. The EPS will grow by 54.11% on average per year.
- Based on estimates for the next years, BWAY will show a quite strong growth in Revenue. The Revenue will grow by 18.80% on average per year.
EPS Next Y77.47%
EPS Next 2Y45.17%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 21.43, the valuation of BWAY can be described as rather expensive.
- 81.72% of the companies in the same industry are more expensive than BWAY, based on the Price/Earnings ratio.
- BWAY's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 28.18.
- With a Price/Forward Earnings ratio of 18.39, BWAY is valued on the expensive side.
- 83.33% of the companies in the same industry are more expensive than BWAY, based on the Price/Forward Earnings ratio.
- Compared to an average S&P500 Price/Forward Earnings ratio of 25.51, BWAY is valued a bit cheaper.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.43 | ||
| Fwd PE | 18.39 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, BWAY is valued a bit cheaper than the industry average as 64.52% of the companies are valued more expensively.
- BWAY's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BWAY is cheaper than 84.41% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 24.49 | ||
| EV/EBITDA | 82.31 |
4.3 Compensation for Growth
- The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
- A more expensive valuation may be justified as BWAY's earnings are expected to grow with 54.11% in the coming years.
PEG (NY)0.28
PEG (5Y)N/A
EPS Next 2Y45.17%
EPS Next 3Y54.11%
5. Dividend
5.1 Amount
- No dividends for BWAY!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
22.93
-0.32 (-1.38%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)11-11 2025-11-11/dmh
Earnings (Next)03-09 2026-03-09/bmo
Inst Owners4.9%
Inst Owner Change1.82%
Ins Owners16.11%
Ins Owner ChangeN/A
Market Cap449.10M
Revenue(TTM)49.09M
Net Income(TTM)6.25M
Analysts85.71
Price Target0.12 (-99.48%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)65.34%
Min EPS beat(2)35.56%
Max EPS beat(2)95.12%
EPS beat(4)3
Avg EPS beat(4)50.32%
Min EPS beat(4)-22.64%
Max EPS beat(4)95.12%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-0.57%
Min Revenue beat(2)-1.07%
Max Revenue beat(2)-0.08%
Revenue beat(4)1
Avg Revenue beat(4)-0.87%
Min Revenue beat(4)-2.35%
Max Revenue beat(4)0.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.3%
Revenue beat(12)6
Avg Revenue beat(12)-11.32%
Revenue beat(16)6
Avg Revenue beat(16)-26.49%
PT rev (1m)-2.45%
PT rev (3m)4.65%
EPS NQ rev (1m)-0.13%
EPS NQ rev (3m)-1.02%
EPS NY rev (1m)5.17%
EPS NY rev (3m)4.7%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.49%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 21.43 | ||
| Fwd PE | 18.39 | ||
| P/S | 9.15 | ||
| P/FCF | 24.49 | ||
| P/OCF | 20.16 | ||
| P/B | 6.41 | ||
| P/tB | 6.41 | ||
| EV/EBITDA | 82.31 |
EPS(TTM)1.07
EY4.67%
EPS(NY)1.25
Fwd EY5.44%
FCF(TTM)0.94
FCFY4.08%
OCF(TTM)1.14
OCFY4.96%
SpS2.51
BVpS3.58
TBVpS3.58
PEG (NY)0.28
PEG (5Y)N/A
Graham Number9.28
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.53% | ||
| ROE | 8.92% | ||
| ROCE | 3.26% | ||
| ROIC | 2.75% | ||
| ROICexc | 15.43% | ||
| ROICexgc | 15.43% | ||
| OM | 5.78% | ||
| PM (TTM) | 12.73% | ||
| GM | 74.92% | ||
| FCFM | 37.36% |
ROA(3y)-8.09%
ROA(5y)-9.73%
ROE(3y)-11.6%
ROE(5y)-14.71%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.39%
GM growth 5Y-0.85%
F-Score5
Asset Turnover0.43
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.08 | ||
| Debt/FCF | 0.37 | ||
| Debt/EBITDA | 1.21 | ||
| Cap/Depr | 207.6% | ||
| Cap/Sales | 8.01% | ||
| Interest Coverage | 26.28 | ||
| Cash Conversion | 470.69% | ||
| Profit Quality | 293.55% | ||
| Current Ratio | 3.19 | ||
| Quick Ratio | 3.02 | ||
| Altman-Z | 6.39 |
F-Score5
WACC8.69%
ROIC/WACC0.32
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)260.14%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%81.08%
EPS Next Y77.47%
EPS Next 2Y45.17%
EPS Next 3Y54.11%
EPS Next 5YN/A
Revenue 1Y (TTM)27.08%
Revenue growth 3Y11.41%
Revenue growth 5Y12.17%
Sales Q2Q%16.38%
Revenue Next Year13.72%
Revenue Next 2Y17.9%
Revenue Next 3Y18.8%
Revenue Next 5YN/A
EBIT growth 1Y147.86%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year6.54%
EBIT Next 3Y43.13%
EBIT Next 5YN/A
FCF growth 1Y441.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y749.36%
OCF growth 3Y127.03%
OCF growth 5YN/A
BRAINSWAY LTD-ADR / BWAY FAQ
What is the fundamental rating for BWAY stock?
ChartMill assigns a fundamental rating of 6 / 10 to BWAY.
Can you provide the valuation status for BRAINSWAY LTD-ADR?
ChartMill assigns a valuation rating of 7 / 10 to BRAINSWAY LTD-ADR (BWAY). This can be considered as Undervalued.
How profitable is BRAINSWAY LTD-ADR (BWAY) stock?
BRAINSWAY LTD-ADR (BWAY) has a profitability rating of 5 / 10.
Can you provide the expected EPS growth for BWAY stock?
The Earnings per Share (EPS) of BRAINSWAY LTD-ADR (BWAY) is expected to grow by 77.47% in the next year.